ABSTRACT
Objective To measure mechanical strain of the lamina cribrosa (LC) after intraocular pressure (IOP) change produced one week after a change in glaucoma medication.
Design Cohort study.
Participants Adult glaucoma patients (23 eyes, 15 patients) prescribed a change in IOP-lowering medication.
Intervention Non-invasive optical coherence tomography (OCT) imaging of the eye.
Main Outcomes Deformation calculated by digital volume correlation of OCT scans of the LC before and after IOP lowering by medication.
Results Among 23 eyes, 17 eyes of 12 persons had IOP lowering ≥ 3 mmHg (reduced IOP group) with tensile anterior-posterior Ezz strain = 1.0% ± 1.1% (p = 0.003) and compressive radial strain (Err) = -0.3% ± 0.5% (p=0.012; random effects models accounting inclusion of both eyes in some persons). Maximum in-plane principal (tensile) strain and maximum shear strain in the reduced IOP group were: Emax = 1.7% ± 1.0% and Γmax = 1.4% ± 0.7%, respectively (both p<0.0001 versus zero). Reduced IOP group strains Emax and Γmax were significantly larger with greater %IOP decrease (<0.0001, <0.0001). The compliance of the Ezz, Emax, and Γmax strain response, defined as strain normalized by the IOP decrease, were larger with more abnormal perimetric mean deviation or visual field index values (all p≥0.02). Strains were unrelated to age (all p≥0.088). In reduced IOP eyes, mean LC anterior border posterior movement was only 2.05 μm posteriorly (p=0.052) and not related to % IOP change (p=0.94, random effects models). Only Err was significantly related to ALD change, becoming more negative with greater posterior LC border change (p=0.015).
Conclusion LC mechanical strains can be effectively measured by changes in eye drop medication using OCT and are related to degree of visual function loss in glaucoma.
Trial Registration ClinicalTrials.gov Identifier: NCT03267849
Competing Interest Statement
The authors have no conflicting relationships related to the drugs or devices used in this research. Heidelberg Engineering donated the imaging device, but were not involved with data analysis or interpretation, nor with drafting of the manuscript.
Clinical Trial
ClinicalTrials.gov Identifier: NCT03267849
Funding Statement
This research was funded in part by NIH NEI R01 EY02120 (Dr. Quigley), P30 EY01765 (Wilmer Institute Core Grant), Research to Prevent Blindness, and the A. Edward Maumenee Professorship (Dr. Quigley) and Brightfocus G2021012S (Nguyen).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of The Johns Hopkins University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest: The authors have no conflicting relationships related to the drugs or devices used in this research. Heidelberg Engineering donated the imaging device, but were not involved with data analysis or interpretation, nor with drafting of the manuscript.
Financial Support: This research was funded in part by NIH NEI R01 EY02120 (Dr. Quigley), P30 EY01765 (Wilmer Institute Core Grant), Research to Prevent Blindness, and the A. Edward Maumenee Professorship (Dr. Quigley) and Brightfocus G2021012S (Nguyen).
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- LC
- lamina cribrosa
- ONH
- optic nerve head
- OCT
- spectral domain optical coherence tomography
- RNFL
- retinal nerve fiber layer
- MD
- mean deviation
- VFI
- visual field index
- IOP
- intraocular pressure
- dB
- decibels
